gehc dividend financial performance and outlook

Gehc's dividend financial performance has been on a steady rise. The company's revenue has consistently increased over the years, with a notable growth of 15% in the last quarter.

In the last fiscal year, Gehc's net income reached a record high of $250 million. This significant increase in net income has allowed the company to distribute a higher dividend to its shareholders.

Gehc's strong financial performance is a result of its diversified business model, which includes a range of products and services. This diversification has enabled the company to reduce its dependence on any one particular market or product.

The company's management has also been praised for its prudent financial management, which has helped to maintain a healthy dividend payout ratio.

Related reading: Ally Financial Dividend

GE HealthCare Technologies (GEHC) has a history of paying dividends since 2023.

The company has distributed four quarterly dividends in the past year, with an annualized dividend per share increase of 13% since twelve months ago.

GEHC's dividend yield has increased by 38% due to the stock price being down by 20% from a year ago.

The company's payout ratio of 2.8% is below the Healthcare sector average of 38.3%, indicating a strong financial position.

GEHC pays dividends on a quarterly basis, with the next payment planned on February 14, 2025.

The dividend amount per share was $0.035, and the ex-dividend date was July 25, 2025.

GEHC's dividend yield is currently 0.18%, which means investors would receive $0.16 in dividends per year for every $100 invested in the company's stock.

The company's annual dividend is $0.14 per share, which is the total amount of dividends paid out to shareholders in a year.

GEHC's payout ratio is 3.22%, indicating that the company can invest in growth opportunities while returning some earnings to shareholders.

Intriguing read: What Does Payout Ratio Mean

GE HealthCare Technologies has been paying dividends since 2023.

The company has a quarterly dividend frequency, meaning you can expect to receive a dividend payout every three months.

GE HealthCare Technologies's last dividend ex-date was on Jul 25, 2025.

Gehc dividend offers a quarterly payment schedule, with four payments made each year. This allows investors to receive regular income from their investment.

The ex-dividend date for gehc dividend is typically set 2-3 business days before the record date. This is when the stock begins trading without the dividend.

Gehc dividend has a history of consistent payments, with a high payout ratio of 70-80% over the past few years. This demonstrates the company's commitment to returning value to its shareholders.

The record date for gehc dividend is usually the same day as the ex-dividend date. This is the day when the company determines which shareholders are eligible to receive the dividend payment.

Curious to learn more? Check out: When Do You Pay Taxes on Dividends

GEHC's dividend yield of 0.16% is relatively low compared to its sector, country, and world peers, but its dividend growth and financial flexibility make it an attractive investment option.

The company's dividend payout ratio of 2.8% ensures safety, with potential to grow as margins recover post-tariff adjustments. This is a rare combination for long-term investors.

GEHC's P/E ratio of 15.59 is below the S&P 500's average, offering valuation support. This makes it an attractive option for conservative growth investors.

Here's a comparison of GEHC's dividend metrics with its peers:

GEHC's balanced approach to prioritizing both returns and R&D appeals to investors seeking stability without sacrificing growth. Its dividend sustainability is further supported by a low payout ratio and strong financials.

GEHC's financial performance is a key factor in its dividend attractiveness. The company reported $19.7 billion in revenue in 2024, with organic growth of 4% in Q1 2025, despite macroeconomic headwinds.

GEHC's diversified revenue stream is driven by key segments like Pharmaceutical Diagnostics (PDx) and AI-enabled imaging, which are growing at 8% and 5% organically, respectively. The company's strong balance sheet is underpinned by $2.5 billion in cash and equivalents and a $1 billion share repurchase program.

Management's revised full-year free cash flow guidance of $1.2 billion reflects prudent risk management rather than structural weakness. This guidance is a result of tariffs, which have affected the company's free cash flow.

Here's a comparison of GEHC's financial metrics with its peers:

GEHC's balanced approach to financials is evident in its low payout ratio and manageable debt-to-equity ratio.

For more insights, see: Price to Dividend Ratio

The healthcare industry is a significant sector for GEHC, with a strong focus on medical imaging and diagnostics. GEHC is a major player in this market, offering a wide range of products and services.

GEHC's medical imaging business is driven by the demand for advanced diagnostic technologies. This demand is fueled by the increasing need for accurate and timely diagnoses, particularly in areas such as cancer and cardiovascular disease.

The company's strong presence in the medical imaging market is a key factor in its success. GEHC's products and services are used in hospitals and clinics around the world, helping healthcare professionals to provide better care.

GEHC's market share in the medical imaging market is substantial, with a significant presence in key regions such as North America and Europe. This market presence is a major contributor to the company's revenue.

GEHC's focus on innovation is driving growth in the medical imaging market. The company is investing heavily in research and development, with a focus on developing new technologies and improving existing ones.

Check this out: 3m Company Stock Splits

GEHC's capital management strategy is a key aspect of its overall financial health. The company has a disciplined approach to its capital structure, as evident from its June 2025 bond issuance of $650 million, carrying a 4.8% coupon and maturing in 2031.

This bond has an investment-grade rating and a high liquidity score of 5.0/5.0, reflecting investor confidence in the company's ability to manage its debt. The proceeds from this bond issuance fund growth initiatives without over-leveraging the balance sheet.

GEHC has also reduced its long-term debt from $9.31 billion in 2024 to $6.76 billion, demonstrating a clear debt-reduction strategy that prioritizes financial resilience. This is a significant improvement, and it sets the company apart from its peers burdened by high-interest debt.

The company's financial flexibility is also evident from its $1 billion stock repurchase program, which signals management's belief that shares are undervalued, especially at its current price near the 50-day moving average of $70.87.

Suggestion: Rithm Capital Dividend

Here's a summary of GEHC's capital management strategy:

GEHC's capital management strategy is a key factor in its overall financial health and stability, making it an attractive option for investors seeking a reliable dividend payer with growth potential.